Retraction. “Phase II study of the anti–insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer”. (Q49020911)
Jump to navigation
Jump to search
scientific article published in November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Retraction. “Phase II study of the anti–insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer”. |
scientific article published in November 2012 |
Statements
1 reference
Retraction. “Phase II study of the anti–insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer”. (English)
1 reference
Daniel D Karp
1 reference
1 November 2012
1 reference
30
1 reference
33
1 reference
4179
1 reference